Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nalmefene in Alcohol Dependence (ESENSE1)
NCT00811720Phase 3Completed
- Sponsor
- Lundbeck
- Start
- Dec 2008
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of nalmefene in alcohol dependence, sponsored by Lundbeck. Started Dec 2008; status: completed.
02
Drugs
nalmefene
03
Conditions
alcohol dependence
Beyond the preview
Go deeper on NCT00811720.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00811720.